HLP
Hongli Group Inc.
$0.5070
-3.61%
$37.9M
No data for this timeframe.
Vol
Market Cap$37.9M
Cap SizeNano Cap
SEC Reports4
Exchange Nasdaq·Sector General Industrial Machinery & Equipment, NEC·CIK 0001855557·Prev Close $0.5260
Recent Activity
May 15, 2026
SEC
Hongli Group is soliciting shareholder approval at an EGM on June 5, 2026, for a comprehensive capital restructuring tha
6-K — Impact 5/10
May 13, 2026
SEC
Hongli Group reported FY2025 revenue of $19.6M (+39% YoY) and net income of $1.9M, a $3.8M turnaround from a $1.9M net l
20-F — Impact 7/10
May 13, 2026
SEC
Hongli Group reported FY2025 results with revenue up 39% to $19.6M and a net income of $1.9M, a $3.8M turnaround from a
6-K — Impact 7/10
Latest Reports
NEUTRAL
6-K
5/10
Hongli Group is soliciting shareholder approval at an EGM on June 5, 2026, for a comprehensive capital restructuring tha
May 15, 2026
BULLISH
20-F
7/10
Hongli Group reported FY2025 revenue of $19.6M (+39% YoY) and net income of $1.9M, a $3.8M turnaround from a $1.9M net l
May 13, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 5.8/10.
NEUTRAL
6-K
5/10
Hongli Group is soliciting shareholder approval at an EGM on June 5, 2026, for a comprehensive capit
May 15, 2026
BULLISH
20-F
7/10
Hongli Group reported FY2025 revenue of $19.6M (+39% YoY) and net income of $1.9M, a $3.8M turnaroun
May 13, 2026
BULLISH
6-K
7/10
Hongli Group reported FY2025 results with revenue up 39% to $19.6M and a net income of $1.9M, a $3.8
May 13, 2026
NEUTRAL
6-K
4/10
Hongli Group Inc. entered into a securities purchase agreement to raise $325,000 through the private
Apr 16, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.